Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Evangelos Giamarellos-Bourboulis and Symeon Metallidis.
Evangelos Giamarellos-Bourboulis
Connection Strength
0.896
Symeon Metallidis
  1. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
    View in: PubMed
    Score: 0.241
  2. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
    View in: PubMed
    Score: 0.233
  3. Integration of heparin-binding protein and interleukin-6 in the early prediction of respiratory failure and mortality in pneumonia by SARS-CoV-2 (COVID-19). Eur J Clin Microbiol Infect Dis. 2021 Jul; 40(7):1405-1412.
    View in: PubMed
    Score: 0.232
  4. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. JAMA. 2018 02 27; 319(8):788-799.
    View in: PubMed
    Score: 0.189
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.